Neurocrine Biosciences NBIX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $721M+199% | $241M-7.0% | $259.1M-4.3% | $270.7M-21.3% | ||
| $767.4M-9.0% | $843.1M+8.0% | $780.5M+7.4% | $726.4M+96.1% | ||
| $2.52B+46.3% | $1.72B+7.3% | $1.61B+10.6% | $1.45B+49.4% | ||
| $89.8M+8.7% | $82.6M+16.7% | $70.8M+20.8% | $58.6M0.0% | ||
| $4.63B+24.5% | $3.72B+14.4% | $3.25B+37.3% | $2.37B+14.3% | ||
| $674.3M+46.1% | $461.6M+2.9% | $448.8M+29.1% | $347.6M+53.9% | ||
| $743.4M+46.4% | $507.7M-22.5% | $654.8M+21.8% | $537.7M+119% | ||
| $1.38B+22.1% | $1.13B+10.8% | $1.02B+54.2% | $660.9M-5.4% | ||
| 220M+219,900% | 100K0.0% | 100K0.0% | 100K0.0% | ||
| $447.7M+1,433% | $29.2M+119% | -$157.1M+61.4% | -$406.8M+36.0% | ||
| $3.25B+25.6% | $2.59B+16.0% | $2.23B+30.7% | $1.71B+24.3% | ||
| $4.63B+24.5% | $3.72B+14.4% | $3.25B+37.3% | $2.37B+14.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neurocrine Biosciences's total assets?
- Neurocrine Biosciences (NBIX) holds $4.9B in total assets, up 33.0% year over year.
- How much debt does Neurocrine Biosciences have?
- Neurocrine Biosciences carries $463.5M in total debt against $3.4B of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Neurocrine Biosciences have?
- Neurocrine Biosciences holds $274.5M in cash and equivalents.
- Can Neurocrine Biosciences cover its short-term obligations?
- Its current ratio is 2.93 — current assets exceed current liabilities.
- Where does Neurocrine Biosciences's balance sheet data come from?
- Every line is extracted from Neurocrine Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
